EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A randomized trial of omega-3 fatty acids plus inositol versus N-acetylcysteine for the treatment of depression and mania in emotionally dysregulated youth age 5–17 with and without autism traits

Janet Wozniak, Maria Iorini, Maura DiSalvo, Hannah O'Connor, Mai Uchida, Hagar Kandel, Atilla Tolga Ceranoglu, Meredith O'Connor, Stephen Faraone, Gagan Joshi

Journal of Affective Disorders · 2026-12 · 414 · 122277

DOI: 10.1016/j.jad.2026.122277 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2026-12. Verfasst von Janet Wozniak und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, MA, USA; Department of Psychia…. Hauptthemen laut MEDLINE: Acetylcysteine, Affective Symptoms, Autistic Disorder, Depression. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Demarest Lloyd Jr Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to assess the effectiveness of the nutraceutical treatments combined omega-3 fatty acid plus inositol (O3I) versus N-acetylcysteine (NAC) in children and adolescents with emotional dysregulation and the impact of the co-occurrence of autism traits (AT). Participants were male and female children (5-17) with emotional dysregulation and the presence/absence of AT, as defined by Child Behavior Checklist score, randomized to receive open-label O3I (1020 mg EPA and 1000-2000 mg Inositol) or NAC (1800-2700 mg) daily for 6 weeks. Clinicians measured severity and improvement of depression and mania with the NIMH Clinical Global Improvement Scale (CGI). Parents completed Parent-Youth Mania Rating Scale (P-YMRS) and Children's Depression Inventory (CDI). Both O3I and NAC resulted in modest improvements in mania and depression and did not differ significantly in between group comparison in their effectiveness. Participants taking O3I, but not NAC, demonstrated statistically significant within group improvement in depression per CDI. Participants taking NAC had a greater decrease in P-YMRS scores versus O3I, but the difference did not reach statistical significance. In the presence of AT, NAC was more effective than O3I for mania but not for depression. Further, participants taking NAC, but not O3I, demonstrated significant within group improvement in SRS and BRIEF scores. These results suggest that O3I and NAC may be beneficial for mania and depression in youth, with trends towards O3I more effective for depression and NAC more effective for mania. The presence of AT in youth with emotional dysregulation may moderate the impact of NAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetylcysteineAffective SymptomsAutistic DisorderDepressionFatty Acids, Omega-3InositolManiaAdolescentChildChild, PreschoolFemaleHumansMaleBipolar DisorderDietary SupplementsDrug Therapy, CombinationPsychiatric Status Rating ScalesTreatment Outcome

Stichwörter der Autor:innen

Autism spectrum disorderEmotional dysregulationInositolN-acetylcysteineOmega-3 fatty acids

Substanzen

AcetylcysteineFatty Acids, Omega-3Inositol

Autor:innen und Institutionen

  • Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA. Electronic address: jwoz…
  • Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, MA, USA.
  • Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
  • Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA.

Förderung

  • Demarest Lloyd Jr Foundation

Zitieren

APA

Wozniak, J., Iorini, M., DiSalvo, M., O'Connor, H., Uchida, M., Kandel, H., Ceranoglu, A. T., O'Connor, M., Faraone, S., & Joshi, G. (2026). A randomized trial of omega-3 fatty acids plus inositol versus N-acetylcysteine for the treatment of depression and mania in emotionally dysregulated youth age 5–17 with and without autism traits. Journal of Affective Disorders, 414, 122277. https://doi.org/10.1016/j.jad.2026.122277

Vancouver

Wozniak J, Iorini M, DiSalvo M, O'Connor H, Uchida M, Kandel H, et al. A randomized trial of omega-3 fatty acids plus inositol versus N-acetylcysteine for the treatment of depression and mania in emotionally dysregulated youth age 5–17 with and without autism traits. Journal of Affective Disorders. 2026;414:122277. doi:10.1016/j.jad.2026.122277

BibTeX
@article{Wozniak2026,
  author = {Wozniak, Janet and Iorini, Maria and DiSalvo, Maura and O'Connor, Hannah and Uchida, Mai and Kandel, Hagar and Ceranoglu, Atilla Tolga and O'Connor, Meredith and Faraone, Stephen and Joshi, Gagan},
  title = {A randomized trial of omega-3 fatty acids plus inositol versus N-acetylcysteine for the treatment of depression and mania in emotionally dysregulated youth age 5–17 with and without autism traits},
  journal = {Journal of Affective Disorders},
  year = {2026},
  volume = {414},
  pages = {122277},
  doi = {10.1016/j.jad.2026.122277}
}
Kostenlos starten →